Biktarvy

Product NDC
50090-6247
11-digit product format
500906247
Labeler code
50090
Product ID
50090-6247_a3c4a0eb-71e8-4b35-9706-240874b78ee0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Application
NDA210251
Marketing category
NDA
Marketing start
2018-02-07
Substance
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Active strength
50; 200; 25 mg/1; mg/1; mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Biktarvy
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BICTEGRAVIR SODIUM50 mg/1
EMTRICITABINE200 mg/1
TENOFOVIR ALAFENAMIDE FUMARATE25 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii4L5MP1Y7W7, G70B4ETF4S, FWF6Q91TZO
Rxcui1999667, 1999673

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
33cd1557-9629-1a35-1f2f-499cf7c608bcProduct name220260305
5f93de8c-a439-4aaa-862f-7cf2524cb240Product name320250812
6286e356-28a5-4b4b-a174-76bf53b211e3Product name620250121
233e3f87-da6c-4b7d-80cb-963ca3258270Product name220240419
dc21b1c2-b0f7-7f56-b95f-dcd93cbc30a4Product name320240320
c0c98dbe-5e23-74e9-f9fc-07af05f77d95Product name820240319
4ef90d80-1289-4267-a2bb-01c741d1208fProduct name120230829
72dcca4e-6eae-4149-a92b-264c2a07004fProduct name120230808
594e2c86-3079-4e6e-96c9-48f7a8afc78dProduct name120230718
1cd1fd33-94db-4c45-bd26-82773ea350a3Product name220220317
14397d46-1c8c-bbf7-f4b7-5a7e59d3690fProduct name420220314
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727
320f244d-8b4e-4893-9f14-104b2a8e0aafProduct name220201007
7ff71f22-5b66-4a3d-bf64-671893a6409dProduct name220201007
6f122144-2ceb-48fa-a906-0d2eb742717eProduct name120190624
8051c8a3-aee0-45a2-a236-8ee3f9e65f67Product name120181211
a56d673d-fa42-4b0e-b5ce-e65a5eab34b7Product name120180911
d1784558-3c5f-4d73-8a7c-051102bb6c92Product name120160405
7fd46899-3505-4ed4-b856-6b2509a76004Product name120151123
0583b5e6-2e6e-c94b-9ff6-81a81ba199deProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-6247-0Biktarvy30 in 1 BOTTLE, PLASTICTABLET305

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-6247-0EA - Each50090-62476c457773-03f9-43c1-8dca-b350d41f5c5112023-01-09

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-6247BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE) TABLET [A-S MEDICATION SOLUTIONS]5Current NDC, Legacy NDC, 1 package rows20240501_0476d7eb-1024-4821-bbe7-abaacfda32a2.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1999667bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral TabletPSN0476d7eb-1024-4821-bbe7-abaacfda32a25
1999673Biktarvy 50 MG / 200 MG / 25 MG Oral TabletPSN0476d7eb-1024-4821-bbe7-abaacfda32a25
1999673bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [Biktarvy]SBD0476d7eb-1024-4821-bbe7-abaacfda32a25
1999667bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral TabletSCD0476d7eb-1024-4821-bbe7-abaacfda32a25
1999667bictegravir 50 MG (as bictegravir sodium 52.5 MG) / emtricitabine 200 MG / tenofovir alafenamide 25 MG (as tenofovir alafenamide fumarate 28 MG) Oral TabletSY0476d7eb-1024-4821-bbe7-abaacfda32a25
1999673Biktarvy 50 MG / 200 MG / 25 MG Oral TabletSY0476d7eb-1024-4821-bbe7-abaacfda32a25

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-6247-05009062470030 TABLET in 1 BOTTLE, PLASTIC (50090-6247-0) 30 tablet2022-11-280000-00-00NoNoCurrent